51264Personalized MECP2 gene therapy using CRISPR/Cas9 technology coupled to AAV-mediated delivery in 3D cell culture and KI mice. [En savoir plus]MECPer-3D - ANR-20-RAR4-0004
EJP RD - 2020

Voir les documents associés 

Exporter

• Export XML
• Export RDF